CMS Finalizes Rule to Simplify Payer-Provider Disputes Under No Surprises Act
CMS finalized a new rule aimed at streamlining the No Surprises Act’s overwhelmed arbitration system. Provider groups largely welcomed the reforms — though some industry leaders said additional changes are still needed to address alleged misuse and improve transparency.
AbbVie’s ADC Strategy Notches Another Win With FDA Approval in Ultra-Rare Blood Cancer
AbbVie drug Decnupaz received FDA approval for treating blastic plasmacytoid dendritic cell neoplasm, or BPDCN. This antibody drug conjugate came from AbbVie’s 2023 ImmunoGen acquisition.
presented by
MedCity FemFwd: The Complicated History Behind Hormone Replacement Therapy
In this episode, we’re joined by Janna Manjelievskaia, director of health economics and outcomes research at Veradigm. We discuss Veradigm’s recent Women’s Health Insights Report, which highlights the complicated history around Hormone Replacement Therapy (HRT), a medication used to treat menopause.
Healthcare AI Is Only As Good As the Systems That Govern It
AI doesn't just demand better processes. It requires a complete redesign of traditional healthcare operations for a new level of precision, traceability, and governance. A new operating model that the vast majority of healthcare organizations simply aren't built around today.
From Close Calls to Safer Systems: Rethinking Near Miss Reporting in Healthcare
To truly drive safety at scale, healthcare organizations will have to look beyond just adverse events and better leverage insights from one of the most valuable, but often underutilized, sources of safety data: near misses.